Actualités

DVA's second-quarter 2026 results show profit growth, but narrowing margins and a weaker commercial mix weigh on the performance.

One Stop Systems (NASDAQ:OSS) reported second-quarter 2026 revenue growth of 62.3% from continuing operations and raised its full-year revenue growth outlook, citing record bookings, expanding customer relationships and increased demand for ruggedized artificial intelligence and high-performance com

BDX's Medical Essentials and Interventional strength may drive third-quarter fiscal 2026 results, but China, vaccines and projected declines weigh on expectations.

Zeta (ZETA) delivered earnings and revenue surprises of 5.00% and +5.36%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Catalyst's Q2 earnings per share are strained by merger costs and loan declines, but higher net interest income, improving credit quality and deposit growth support results.

Circle Stock Under Pressure After Q2 Beat as USDC Misses Expectations

SpaceX reported its first quarterly results as a public company, beating on revenue but falling 11% as investors focused on heavy capital spending. Its 18,712 bitcoin lost roughly $195 million in value during the quarter. CoinDesk's Jennifer Sanasie hosts "CoinDesk Daily."

IPG Photonics beats Q2 earnings estimates as Industrial Solutions growth, led by battery manufacturing, lifts revenues and margins.

ALAB's Q2 earnings and revenues top estimates as PCIe 6 drives over half of sales and Scorpio X-Series ramp-up toward a stronger third quarter.

Advanced Energy's Q2 earnings beat as record semiconductor sales, AI-driven data center demand and factory execution lift revenues and margins.

TMDX's Q2 revenue beat and raised outlook are overshadowed by earnings miss, declining margins and sharply higher operating costs.

SolarEdge is working on a turnaround -- but it's a work in progress.

Galaxy Digital (GLXY) shares fell more than 11% on Aug. 5 after the crypto financial services firm reported a second-quarter net loss of $85 million, weighed down by falling digital asset prices despite continued expansion of its artificial intelligence infrastructure business. The company posted ...

Analysts raised price targets after earnings, while bullish retail traders said AMD could climb as high as $800 on AI-driven growth.

Moby summary of SolarEdge Technologies, Inc.'s Q2 2026 earnings call

The storage and memory maker is scheduled to report fiscal fourth-quarter financials after the stock market closes on Wednesday.

PBA misses Q2 EPS estimates, but revenues rise 20% year over year as higher volumes and operational strength lift results across its business segments.

SPOT's Q2 earnings miss estimates as higher marketing, cloud and AI costs offset record margins, subscriber gains and stronger cash flow.

Kymera Therapeutics (NASDAQ:KYMR) said it completed enrollment in its Phase 2b atopic dermatitis trial of KT-621 about six months ahead of schedule, positioning the company to report top-line data by the end of 2026 and potentially begin Phase 3 development around mid-2027. Chief Executive Officer

Kratos's earnings last night weren't quite as good as they first appeared.

Moby summary of The Kraft Heinz Company's Q2 2026 earnings call

Moby summary of Innoviz Technologies Ltd.'s Q2 2026 earnings call

DVN's Q2 earnings beat estimates as merger contributions, stronger oil pricing and higher output drive a 73.1% revenue surge and robust free cash flow.

WYNN's Q2 earnings and revenues beat estimates and rise year over year, as Wynn Palace drives growth with a 21.1% revenue increase.

Moby summary of CDW Corporation's Q2 2026 earnings call

Sezzle enters Q2 earnings with strong growth momentum, but elevated valuation and margin pressures raise the stakes after a 106% three-month rally.

Palantir's Q2 may have finally justified its lofty premium.

QRVO beat earnings estimates as stronger margins and cost discipline offset weaker smartphone demand, highlighting a profitability story driven by execution.

Moby summary of CVS Health Corporation's Q2 2026 earnings call

SHEL tops Q2 earnings estimates as higher oil prices, stronger margins and broad operational gains lift profits across key segments.